Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines

JAMA. 2021 Aug 17;326(7):589-590. doi: 10.1001/jama.2021.12915.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Neutralizing
  • Antibodies, Viral / blood*
  • COVID-19 / immunology*
  • COVID-19 / therapy
  • COVID-19 Vaccines* / immunology
  • Humans
  • Immunotherapy
  • SARS-CoV-2 / immunology*
  • Spike Glycoprotein, Coronavirus / chemistry

Substances

  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2